This paper reports on the advantages and disadvantages of using buccal opioids for breakthrough pain relief with a focus on diamorphine as the preferred opioid. The paper shares the clinical experiences from one UK organisation of care for children and young people at the end of their lives and contributes to the growing body of pharmacological evidence.
Norman, C. & Maynard, L. 2019. Buccal opioids for breakthrough pain in children with life-limiting conditions receiving end-of-life care. International Journal of Palliative Nursing, 25 (10) p 112-117.
Request a copy from the library